Regulating VEGF signaling in platelet concentrates via specific VEGF sequestering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Vascular Biology

Background:

• Platelets are rich in growth factors crucial for wound healing.
• Unregulated platelet-derived Vascular Endothelial Growth Factor (VEGF) can impair wound healing.
• Current methods for platelet activation yield varying levels of growth factors.

Purpose of the Study:

• To develop poly(ethylene glycol) (PEG) microspheres capable of capturing and regulating VEGF from human platelets.
• To assess the efficacy of freeze-thaw platelet activation compared to other methods.
• To evaluate the ability of VEGF-binding peptide (VBP) functionalized microspheres to sequester VEGF and reduce platelet concentrate bioactivity.

Main Methods:

• Human platelets were activated using freeze/thaw, calcium chloride, PAR1AP, or thrombin treatments.
• PEG microspheres functionalized with a VEGF-binding peptide (VBP) derived from VEGFR2 were synthesized.
• VEGF levels in activated platelet concentrates were quantified.
• The bioactivity of platelet concentrate treated with VBP microspheres was assessed using HUVEC culture.

Main Results:

• Platelet freeze/thaw activation yielded significantly higher levels of VEGF compared to other tested methods.
• VBP-functionalized PEG microspheres successfully sequestered VEGF from freeze-thaw activated platelet concentrate.
• VBP microspheres reduced the bioactivity of platelet concentrate in HUVEC culture, indicating effective VEGF sequestration and activity reduction.

Conclusions:

• Freeze-thaw is an effective method for releasing high levels of VEGF from human platelets.
• VEGF-sequestering microspheres demonstrate the ability to capture and regulate VEGF activity from autologous platelet products.
• This technology holds promise for controlling growth factor activity in platelet-rich therapies for wound healing.